Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors identified by computer-aided drug design
Colin M. Tice, David A. Claremon, Gerard M. McGeehan, R. David Simpson(Institute of Forest Science), Barbara A. Kruk, Joan Guo, Richard K. Harrison(Tel Aviv University), Jennifer Berbaum, Reshma Panemangalore, Paula M. Krosky, Yuri Bukhtiyarov, Wei Zhao, Suresh B. Singh(Unknown), Brian M. McKeever(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yuan-Jie Ye, Salvacion Cacatian, Wei He(Northeast Agricultural University), Zhenrong Xu(Minzu University of China), Boyd B. Scott, Linghang Zhuang, Judith Johnson, Joseph G. Bruno, Peter Lindblom, Yi Zhao(National University of Singapore)
Cited by 25
Related Papers
Protein Crystal Growth in Microgravity
|Science|1989|191
<i>C</i>-Glycosidation Technology With Free Radical Reactions
|Synlett|1998|151
Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women
|Frontiers in Cellular and Infection Microbiology|2019|150
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
|British Journal of Pharmacology|2012|121
Numerically calibrated model for propagation of a relativistic unmagnetized jet in dense media
|Monthly Notices of the Royal Astronomical Society|2018|92